NCT04581785: A reported trial by LogicBio Therapeutics, Inc.
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT04581785 |
|---|---|
| Title | A Phase 1/2 Open-label Clinical Study of hLB-001 Gene Therapy in Pediatric Patients With Methylmalonic Acidemia Characterized by MMUT Mutations |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | May 29, 2021 |
| Completion date | Jan. 10, 2023 |
| Required reporting date | Jan. 10, 2024, midnight |
| Actual reporting date | Jan. 5, 2024 |
| Date last checked at ClinicalTrials.gov | Aug. 26, 2025 |
| Days late | None |